EDGAR Filing Documents for 0001193125-23-214555

Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:

SEC Accession No. 0001193125-23-214555

Filing Date

2023-08-17

Accepted

2023-08-16 21:25:31

Documents

Period of Report

2023-08-16

Document Format Files

Seq	Description	Document	Type	Size
1	6-K	d358180d6k.htm	6-K	11135
2	EX-99.1	d358180dex991.htm	EX-99.1	1620939
3	EX-99.2	d358180dex992.htm	EX-99.2	20729
4	EX-99.3	d358180dex993.htm	EX-99.3	10648
5	EX-99.4	d358180dex994.htm	EX-99.4	192837
6	EX-99.5	d358180dex995.htm	EX-99.5	6544
7	GRAPHIC	g3581801sp7.jpg	GRAPHIC	62792
8	GRAPHIC	g358180g15a05.jpg	GRAPHIC	369473
9	GRAPHIC	g358180g15a06.jpg	GRAPHIC	217674
10	GRAPHIC	g358180g32m72.jpg	GRAPHIC	12302
11	GRAPHIC	g358180g83c46.jpg	GRAPHIC	4106
12	GRAPHIC	g492040g0815233618767.jpg	GRAPHIC	12527
13	GRAPHIC	g492040g0816004139104.jpg	GRAPHIC	4205
14	GRAPHIC	g492040g70b16.jpg	GRAPHIC	13566
15	GRAPHIC	g492040g74i76.jpg	GRAPHIC	12173
16	GRAPHIC	g492040snap35.jpg	GRAPHIC	2604
	Complete submission text file	0001193125-23-214555.txt		2844339

Mailing Address 440 ARMAND-FRAPPIER BLVD. SUITE 300 LAVAL A8 H7V 4B4

Business Address 231 DUNDAS STREET EAST BELLEVILLE A6 K8N 1E2 450-781-0115

Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)